Back to top
more

Alcon (ALC)

(Real Time Quote from BATS)

$73.10 USD

73.10
417,926

-0.60 (-0.81%)

Updated Aug 25, 2026 12:32 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 39% (149 out of 246)

Industry: Medical - Instruments

Zacks News

Zacks Equity Research

Company News for Nov 13, 2025

Companies in The News Are: LEGN, ONON, PLTR, ALC

Zacks Equity Research

ALC's Q3 Earnings Beat, Revenues Miss, Stock Rises in After-Market Hours

Alcon posts mixed Q3 results as earnings top estimates but revenues miss; new product launches fuel optimism.

Zacks Equity Research

Alcon (ALC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Alcon (ALC) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks Equity Research

Mettler-Toledo Q3 Earnings Top Estimates, Sales Decline Y/Y

MTD posted stronger-than-expected Q3 results, lifted by segment growth and solid guidance for 2025 and 2026.

Zacks Equity Research

SOLV Gains on Q3 Earnings & Sales Beat, Raises '25 EPS Outlook

Solventum posts strong Q3 results with a revenue and earnings beat, lifts 2025 EPS guidance on solid MedSurg and HIS growth.

Indrajit Bandyopadhyay headshot

XRAY Stock Declines on Q3 Earnings Miss & Lower 2025 EPS View

DENTSPLY SIRONA shares drop as Q3 earnings miss estimates and 2025 EPS guidance is cut amid segment weakness.

Zacks Equity Research

Curious about Alcon (ALC) Q3 Performance? Explore Wall Street Estimates for Key Metrics

Evaluate the expected performance of Alcon (ALC) for the quarter ended September 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Zacks Equity Research

Avanos Medical Gains on Q3 Earnings Beat, Raises '25 Sales View

Avanos Medical posts a Q3 earnings and sales beat, boosts 2025 outlook as Specialty Nutrition drives solid double-digit growth.

Zacks Equity Research

MCK Q2 Earnings Beat, Sales Miss, '26 EPS View Up, Stock Down

McKesson posts a strong Q2 earnings beat but a slight sales miss, lifts its 2026 EPS outlook on solid specialty and tech segment growth.

Zacks Equity Research

Waters Q3 Earnings Surpass Estimates, Revenue Increase Y/Y

WAT posts strong Q3 results with 16% earnings growth and higher sales, lifting its full-year outlook for 2025.